TCIM
CUE icon

TIAA CREF Investment Management’s Cue Biopharma CUE Stock Holding History

TIAA CREF Investment Management’s Portfolio CUE Stock Details CUE Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2019
Q1 		$236K Sell
1,017
-337
-25% -$64.1K ﹤0.01% 2852
2018
Q4 		$191K Buy
1,354
+89
+7% +$16.2K ﹤0.01% 2885
2018
Q3 		$343K Sell
1,265
-28
-2% -$8.09K ﹤0.01% 2849
2018
Q2 		$460K Buy
+1,293
New +$514K ﹤0.01% 2818

Other funds holding CUE

BlackRock
BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return
NCM
Nantahala Capital Management New Canaan, Connecticut $2.72B AUM 121.58% 1-Year Est. Return
Vanguard Group
Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return
State Street
State Street Boston, Massachusetts $2.9T AUM 29.55% 1-Year Est. Return
Northern Trust
Northern Trust Chicago, Illinois $757B AUM 28.64% 1-Year Est. Return
Geode Capital Management
Geode Capital Management Boston, Massachusetts $1.61T AUM 30.72% 1-Year Est. Return
Bank of New York Mellon
Bank of New York Mellon New York $544B AUM 28.31% 1-Year Est. Return
SFM
Sphera Funds Management Tel Aviv, Israel $630M AUM 108.65% 1-Year Est. Return
Charles Schwab
Charles Schwab San Francisco, California $654B AUM 26.35% 1-Year Est. Return
SPC
Sigma Planning Corp Ann Arbor, Michigan $3.6B AUM 24.57% 1-Year Est. Return

TIAA CREF Investment Management's CUE Position: Q1 2019 in Review

TIAA CREF Investment Management reduced its Cue Biopharma (CUE) stake by 25% in Q1 2019, selling an estimated $64.1K and leaving 1,017 shares worth $236K. The position accounts for ﹤0.01% of the portfolio, ranked #2852.

TIAA CREF Investment Management first reported a position in CUE in Q2 2018 and has held it in 4 quarters since. The position peaked at $460K in Q2 2018. 38 funds tracked by Wall St. Rank hold CUE as of Q1 2019.

  • TIAA CREF Investment Management held 1,017 shares of Cue Biopharma worth $236K as of Q1 2019.
  • TIAA CREF Investment Management sold 337 Cue Biopharma shares in Q1 2019, an estimated $64.1K.
  • Cue Biopharma made up ﹤0.01% of TIAA CREF Investment Management's portfolio in Q1 2019, its #2852 holding.
  • TIAA CREF Investment Management first reported a position in Cue Biopharma in Q2 2018 and has held it in 4 quarters since.
  • TIAA CREF Investment Management's Cue Biopharma position peaked at $460K in Q2 2018.
  • 38 funds tracked by Wall St. Rank held Cue Biopharma as of Q1 2019.

Based on TIAA CREF Investment Management's 13F filing for Q1 2019, filed 14 May 2019.